KRT18 and metabolic dysfunction-associated steatotic liver disease: In our previous study [26], CK-18 M30 was significantly increased in patients manifesting CHB with NAFLD and was positively correlated with ALT, TG, FBG, histology inflammation score, fibrosis score, and steatosis.